icon
An official government website affiliated with the Government of the Kingdom of Saudi Arabia.
icon Sat 17 Oct 2026
Beta version
icon
Official Saudi government website domains end with gov.sa

All official websites of government entities in the Kingdom of Saudi Arabia end with.gov.sa.

icon
Official Reliable websites use HTTPS

Ensure the website is using the HTTPS protocol.

icon

Registered with the Digital Government Authority under number:

20250831619
Suggestions

Drug Approvals

SFDA Approved Use

Glycerol Phenylbutyrate is indicated for use as adjunctive therapy for chronic management of patients with urea cycle disorders (UCDs)including deficiencies of carbamoyl phosphate synthetase I (CPS), ornithine carbamoyltransferase (OTC),argininosuccinate synthetase (ASS), argininosuccinate lyase (ASL), arginase I (ARG) and ornithine translocasedeficiency hyperornithinaemia-hyperammonaemia homocitrullinuria syndrome (HHH) who cannot be managed by dietaryprotein restriction and/or amino acid supplementation alone.
Glycerol Phenylbutyrate must be used with dietary protein restriction and, in some cases, dietary supplements (e.g., essential aminoacids, arginine, citrulline, protein-free calorie supplements).